Abstract:Background 7-Methylguanosine (m 7 G) is one of the most conserved modifications in nucleosides within tRNAs and rRNAs. It plays essential roles in the regulation of mRNA export, splicing, and translation. Recent studies highlighted the importance of METTL1-mediated m 7 G tRNA methylome in the self-renewal of mouse embryonic stem cells (mESCs) through its ability to regulate mRNA translation. However, the exact mechanisms by which METTL1 regulates pluripotency and differentiation in human induced pluripotent stem cells (hiPSCs) remain unknown. In this study, we evaluated the functions and underlying molecular mechanisms of METTL1 in regulating hiPSC self-renewal and differentiation in vivo and in vitro. Methods By establishing METTL1 knockdown (KD) hiPSCs, gene expression profiling was performed by RNA sequencing followed by pathway analyses. Anti-m 7 G northwestern assay was used to identify m 7 G modifications in tRNAs and mRNAs. Polysome profiling was used to assess the translation efficiency of the major pluripotent transcription factors. Moreover, the in vitro and in vivo differentiation capacities of METTL1-KD hiPSCs were assessed in embryoid body (EB) formation and teratoma formation assays. Results METTL1 silencing resulted in alterations in the global m 7 G profile in hiPSCs and reduced the translational efficiency of stem cell marker genes. METTL1-KD hiPSCs exhibited reduced pluripotency with slower cell cycling. Moreover, METTL1 silencing accelerates hiPSC differentiation into EBs and promotes the expression of mesoderm-related genes. Similarly, METTL1 knockdown enhances teratoma formation and mesoderm differentiation in vivo by promoting cell proliferation and angiogenesis in nude mice. Conclusion Our findings provided novel insight into the critical role of METTL1-mediated m 7 G modification in the regulation of hiPSC pluripotency and differentiation, as well as its potential roles in vascular development and the treatment of vascular diseases.

Melatonin restores the pluripotency of long-term-cultured embryonic stem cells through melatonin receptor-dependent m6A RNA regulation

m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency

N6-methyladenosine (m6A) depletion regulates pluripotency exit by activating signaling pathways in embryonic stem cells

Targeted RNA <i>N</i><SUP>6</SUP>-Methyladenosine Demethylation Controls Cell Fate Transition in Human Pluripotent Stem Cells

Melatonin-Mediated Upregulation Of Glut1 Blocks Exit From Pluripotency By Increasing The Uptake Of Oxidized Vitamin C In Mouse Embryonic Stem Cells

The N6-Methyladenosine RNA modification in pluripotency and reprogramming

Profiling the role of m6A effectors in the regulation of pluripotent reprogramming

Melatonin Plays Critical Role in Mesenchymal Stem Cell-Based Regenerative Medicine in Vitro and in Vivo.

M(6)a RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells.

METTL1-mediated m7G methylation maintains pluripotency in human stem cells and limits mesoderm differentiation and vascular development

Melatonin Improves The Reprogramming Efficiency Of Murine-Induced Pluripotent Stem Cells Using A Secondary Inducible System

M6a Regulates Neurogenesis and Neuronal Development by Modulating Histone Methyltransferase Ezh2

METTL1-mediated m 7 G methylation maintains pluripotency in human stem cells and limits mesoderm differentiation and vascular development

RNA m6A modification regulates cell fate transition between pluripotent stem cells and 2-cell-like cells

N6-Methyladenosine Methyltransferases and Demethylases: New Regulators of Stem Cell Pluripotency and Differentiation

Steering pluripotency and differentiation with N6-methyladenosine RNA modification

Melatonin Promotes the Acquisition of Neural Identity Through Extracellular-Signal-regulated Kinases 1/2 Activation.

Stage-specific requirement for m6A RNA methylation during cardiac differentiation of pluripotent stem cells

Methyltransferases Modulate RNA Stability in Embryonic Stem Cells

m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner

Effects and Mechanisms of Melatonin on Neural Differentiation of Induced Pluripotent Stem Cells